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Abstract.  We have recently characterized a chondroi- 
tin sulfate proteoglycan from the murine central ner- 
vous system which is expressed by astrocytes in vitro 
and carries the L2/HNK-1 and L5 carbohydrate struc- 
tures.  In the present study, we provide evidence that 
its three core proteins of different size are similar in 
their proteolytic peptide maps and thus designate this 
group of structurally related molecules astrochondrin. 
During development, astrochondrin and the L5 carbo- 
hydrate were hardly detectable in the brain of 14-d-old 
mouse embryos by Western blot analysis.  Expression 
of astrochondrin and the L5 epitope was highest at 
postnatal day 8,  the peak of cerebellar granule cell mi- 
gration and Bergmann glial process formation,  and 
decreased to weakly detectable levels in the adult.  Im- 
munocytochemical localization of astrochondrin  in the 
cerebellar cortex of 6-d-old mice showed association 
of immunoreactivity with the cell surface of astrocytes, 
including Bergmann glial processes and astrocytes in 
the internal  granular  layer or prospective white matter. 
Endfeet of astrocytes contacting the basal lamina of 
endothelial and meningeal  cells and contact sites be- 
tween Bergmann glial processes and granule cells also 
showed detectable levels of astrochondrin.  Furthermore, 
granule cell axons in the molecular layer were astro- 
chondrin immunoreactive.  In the adult,  astrochondrin 
immunoreactivity was weakly present in the internal 
granular  layer and white matter. 
Both Fab fragments of polyclonal antibodies to astro- 
chondrin and monovalent fragments of the L5 mono- 
clonal antibody reduced the formation of processes of 
mature GFAP-positive astrocytes on laminin and colla- 
gen type IV, but not on fibronectin as substrata. Inter- 
estingly, the initial attachment of astrocytic cell bodies 
was not disturbed by these antibodies. Antibodies to as- 
trochondrin also reduced the migration of granule cells 
in the early postnatal mouse cerebellar cortex. 
In a solid phase radioligand binding assay,  astrochon- 
drin was shown to bind to the extracellular matrix 
components laminin  and collagen type IV, being en- 
hanced in the presence of Ca  2§  but not to fibronectin, 
J1/tenascin or other neural recognition molecules. Fur- 
thermore,  astrochondrin  interacted with collagen types 
III and V, less strongly with collagen types I, II, and 
IX, but not with collagen type VI.  The interaction of 
astrochondrin  with collagen types III and V  was satu- 
rable and susceptible to increasing  ionic strength,  and 
could be competed by chondroitin sulfate, heparin, and 
dextran sulfate, but not by hyaluronic acid,  glucose- 
6-phosphate,  or neuraminic  acid. 
These observations indicate that astrochondrin  may 
contribute to morphogenetic processes in the develop- 
ing central nervous system by supporting the interac- 
tion of astrocytes with extracellular matrix components, 
such as laminin and certain collagen types, thus influ- 
encing their capacity to extend their processes, possi- 
bly by interacting  with the basal lamina of meninges 
and blood vessels. These interactions appear to be, at 
least in part, dependent on the L5 carbohydrate epitope. 
TROCYTES participate in numerous processes essen- 
tial for the morphogenesis and functional  mainten- 
ance of the central  nervous  system (for reviews see 
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Vernadakis,  1988; Jessen and Mirsky,  1990;  Hertz et al., 
1990). In the developing vertebrate brain, radial  glial cells 
constitute  one of the first cell types to form a characteristic 
cellular element destined to guide migrating  neuronal  cell 
bodies to their target positions (Rakic,  1972). These radial 
glia abut with their endfeet upon the pial surface on one side 
and the ventricular lumen on the other, thus forming a spatial 
roster for the assembly of functional  neuronal  units (Rakic, 
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to appose their endfeet onto the abluminal side of capillaries 
or onto the pia mater, all in close association with the basal 
lamina of endothelial and meningeal cells. Such contacts ap- 
pear to be instrumental in the determination of tight junc- 
tions between endothelial cells (Janzer and Raft, 1987) and 
are characterized by intramembranous specializations in the 
plasma membrane of astrocytes (Landis and Reese, 1982). 
Astrocytic  endfeet also  appear  in  close  association with 
myelinated axons at the node of Ranvier (for review see 
Black and Waxman, 1988) and thus have been implicated in 
the development and maintenance of internodal specializa- 
tions, possibly by topically restricted expression of recogni- 
tion molecules in the extraceUular matrix (French-Constant 
et al.,  1986).  A metamorphosis in glial morphology is not 
only observed during development, when radial gila trans- 
form into astrocytes, but also after damage to the adult ner- 
vous system. Astrocytic gliosis is accompanied by extensive 
process outgrowth and changes in the disposition of the cyto- 
skeleton (Bignami and Ralston,  1969;  Latov et al.,  1979; 
Janeczko, 1989;  Davis et al.,  1990). 
These observations have elicited an interest in the cellular 
and molecular determinants underlying the elaboration of 
astrocytic morphology in the context of their interactions 
with the surrounding target structures. Growth factors have 
been found to alter the morphological appearance of astro- 
cytes  in  vitro  (Toru-Debauffe  et  al.,  1990),  possibly by 
influencing intracellular messenger systems including pro- 
tein  kinase  C  (Harrison  and  Mobley,  1990)  and  cAMP 
(Cavanaugh et al., 1990).  Also neurons have been shown to 
influence the morphology and proliferative behavior of as- 
trocytes  in  vitro  (Hatten,  1985;  Nagata  and  Schachner, 
1986; Gasser and Hatten, 1990; Rogister et al., 1990). Fur- 
thermore, neurons influence the expression of cell surface 
components on astrocytes (Nagata and Schachner, 1986) and 
may thus determine their communication with the cellular 
and acellular environment. The expression of extracellular 
matrix components, such as the glia-associated glycoprotein 
tenascin, appears to correlate with characteristic morpho- 
logical features of astrocytes (Gierson et al.,  1990). 
Recently, we have characterized a chondroitin sulfate pro- 
teoglycan containing three core protein moieties which is ex- 
pressed by cultured astrocytes and not by other neural cell 
types in the murine central nervous system (Streit et al., 
1990). This proteoglycan was isolated by virtue of its expres- 
sion of the novel L5 carbohydrate epitope recognized by 
the monoclonal L5 antibody. This antibody recognizes an 
N-linked carbohydrate structure additionally, but much less 
prominently, present on other molecules in the central ner- 
vous system, such as the recognition molecules L1 or Thy-1 
(Tiveron et al., 1992).  Although the latter molecules carry 
the L5 carbohydrate, astrochondrin is the only L5-positive 
molecule expressed by astrocytes (Streit et al.,  1990).  The 
L5 epitope itself appears to play an important role during 
early neurogenesis in chicken (Roberts et al., 1991). More- 
over, the L5 expressing chondroitin sulfate proteoglycan was 
shown to be a new member of  the L2/HNK-1 family of recog- 
nition molecules (Kruse et al., 1984,  1985; Schachner et al., 
1990).  These observations encouraged us to investigate the 
functional properties of this proteoglycan in the interactions 
between different  neural cell types and their surrounding ma- 
trix. Here, we show that the three core proteins of the pro- 
teoglycan are structurally closely related to each other on the 
basis of similar proteolytic peptide maps. Furthermore, we 
provide evidence that the proteoglycan is involved in cerebel- 
lar granule cell migration and process formation of astro- 
cytes on specific substrata, such as laminin and collagen type 
IV. Independently, binding assays demonstrate a specific in- 
teraction between the proteoglycan and these extracellular 
matrix components. Immunoelectron microscopic investiga- 
tions show a distinct localization of the proteoglycan in close 
contact with the basal lamina of meningeal and endothelial 
cells, thus colocalizing with laminin and collagen type IV. 
Because of its unique association with astrocytes and since 
it contains chondroitin sulfate as glycosaminoglycan  compo- 
nent we have named it astrochondrin. 
Materials and Methods 
ExtraceUular Matrix Components and 
Adhesion Molecules 
Collagens I, II, HI, IV, V, VI, and IX, were purified as described by Fahrig 
et al. (1987) and kindly provided by Dr. K. Kfihn (Max-Planck-Institute  for 
Biochemistry,  Martinsried, Germany). Collagen G (Seromed,  Heidelberg, 
Germany) consists of collagen  types I (90%) and HI (10%).  Englebreth- 
Holm sarcoma laminin and human plasma fibronectin  were purchased from 
Bethesda Research Laboratories (Galthersburg,  MD). Rat chondrosarcoma 
chondroitin sulfate proteoglycan (ICN, Rediochemicals,  Irvine, CA), hepa- 
rin (No. 375095; Calbiochem-Behring  Corp., San Diego, CA), chondroitin 
sulfate (No. 230687;  Calbiochem-Behring Corp.), dextran sulfate (No.  D 
4911; Sigma Chemical Co.), hyaluronic acid (No. H 4015; Sigma Chemical 
Co.),  glucose-6-phosphate  (Sigma  Chemical Co.)  and neuraminic acid 
(Sigma Chemical Co.) were obtained commercially. The cell adhesion mol- 
ecule L1 (Rathjen and Schachner,  1984), the neural cell adhesion molecule 
(N-CAM) l (Him et al.,  1981), the myelin-associated  glycoprotein  (MAG) 
(Fahrig et al.,  1987), the adhesion molecule on glia (AM(M3) (Antonicek 
et al.,  1987), Jl/tenascin (Faissner et al.,  1988), and J1-160/180 (Kruse et 
al.,  1985;  Posheva et al.,  1989) were purified  from mouse brain by im- 
munoaffinity  chromatography as described. AMOG was a kind gift from 
Dr. H. Antonicek, J1/tenascin from Dr. K. Husmann and J1-160/180 from 
Dr. B. Furl (Department of Neurobiology,  Swiss Federal Institute of Tech- 
nology, Ztirich).  Astrochondrin was purified from early postnatal mouse 
brain by sequential  immunoaffinity  chromatography on a monoclonal L5 
antibody column after removal of L1 (Rethjen and Schachner,  1984) and 
syneuran (Faissner et al., 1992) followed by anion exchange chromatogra- 
phy (Streit et al.,  1990). 
Antibodies 
Polyclonal  antibodies to glial fibrillary acidic  protein (GFAP) were pur- 
chased from DAKOPATTS (Copenhagen, Denmark). Polyclonal antibodies 
to astrochondrin were raised in rabbits (Streit et al., 1990) and purified by 
protein A affinity chromatography using fast protein liquid chromatography 
(FPLC) (Pharmacia/LKB; Upsala, Sweden). Fab fragments were generated 
according  to Porter (1959).  Fig.  1 shows the specificity of the polyclonal 
astrochondrin antibodies for the proteoglycan  purified  by the  L5  mAb 
column (Fig.  1 A); there is no reaction detectable with other, I..5 negative 
proteoglycans.  When Western blots of total brain homogenates digested 
with chondroitinase ABC were probed with the antibodies,  only the three 
core proteins described for astrochondrin (Fig.  1 B, lanes 2 and 3) could 
be identified again showing their specificity for the proteoglycan.  Polyclonal 
antibodies to astrochondrin only react with cultured astrocytes and not with 
neurons or oligodendrocytes  as shown by immunoprecipitation of radioac- 
tively labeled cells (Fig.  1 C). 
Monoclonal L5 antibody (Streit et al.,  1990) was purified  from the as- 
cites fluid of nu/nu mice carrying L5 hybridoma cells or from the superna- 
1. Abbreviations  used in this paper: AMOG, adhesion molecule on glia; 
BrdU,  bromodeoxyuridine; CTB,  cytotactin binding; FPLC,  fast protein 
liquid chromatography; GFAP, glial fibrillary acidic protein; MAG, myelin- 
associated  glycoprotein;  MI, migratory index;  N-CAM, neural cell adhe- 
sion molecule. 
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drin. (A) Using polyclonal antibodies to astrochondrin in Western 
blot analysis of the protein fractions binding (lane 1) and not bind- 
ing (lane 2) to the L5 monoclonal antibody column. Only the pro- 
teoglycan binding to the L5  column is reactive.  (B) Crude total 
brain homogenates from 8  (lanes 1  and 2) and  15  (lane 3) d-old 
mice were used for Western blot analysis before (lane 1) and after 
treatment with chondroitinase ABC (lanes 2  and 3) and assayed 
with polyclonal antibodies to astrochondrin. The antibodies only 
recognize the three core proteins described for astrochondrin (ar- 
rows). (C) Immunoprecipitation of [35S]methionine labeled astro- 
cytes  (lane  1),  oligodendrocytes (lane 2),  and neurons  (lane 3) 
using polyclonal antibodies to astrochondrin. Astrochondrin is only 
detectable in astrocyte cultures.  The faint band detected in oligo- 
dendrocytes is due to the presence of precursor cells and few con- 
taminating astrocytes. Molecular weights of standard protein mix- 
tures are indicated at the left margins. 
tant of hybridoma cells cultured in I% Nutridoma (Boehringer Mannheim 
Biochemicals,  Indianapolis, IN) by affinity chromatography on a mouse 
anti-rat kappa chain column (Bazin, 1982). Monovaient  fragments were ob- 
tained from the L5 IgM antibodies by tryptic digestion as described by 
Matthew and Reichardt (1982). The rat mAb 412 to the L2/HNK-I carbohy- 
drate epitope was obtained by immunization of Lou x Sprague  Dawley FI 
hybrid female rats with crude membrane fractions of early postnatal mouse 
cerebellum following the procedures described by Kruse et ai. (1984). Poly- 
clonal antibodies to mouse liver membranes (LiMner et al.,  1982) and to 
L1 (Rathjen and Schachner, 1984) were generated in rabbits  by Dr. V. Kiine- 
mum and A. Spitzauer at the Department of Neurobiology (University of 
Heidelberg). 
Alkaline phosphatase-coupled antibodies to rabbit IgG (Promega Bio- 
tec, Madison, WI) or mouse IgM (Dianova, Hamburg, Germany) were used 
as secondary antibodies for Western blot analysis. For indirect immunofluo- 
rescence, primary antibodies were visualized  by FITC-conjngated  swine an- 
tibodies to rabbit IgG (Dakopatts)  or FITC-conjngated  goat antibodies to 
rat Ig (Cappel Laboratories, Cochranville, PA) or TRITC-conjugated  goat 
antibodies to mouse Ig (Dianova).  For immunoelectron microscopy,  pri- 
mary antibodies were visualized by HRP-coupled  protein A (Signm Chemi- 
cal Co.) at a concentration of 0.75 #g/ml. 
Peptide Mapping 
Immature cerebellar astrocytes  were metabolically labeled with [35S]me- 
thionine followed by immunoprecipitation with polyclonai antibodies to as- 
trochoMrin as described previously (Streit et al.,  1990).  Collected im- 
munoprecipitates were washed twice with 50 mM Tris-acetate,  pH  8.0, 
containing 1 mM ovomucoid (Sigma Chemical Co.) and 1 mM PMSF and 
digested  with chondroitinase ABC (Boehringer Maanheim Biochemicals) 
in the same solution for 3 h at 37~  using 10 mU per precipitate. Then, 
I vol of 40 mM sodium phosphate buffer, pH 7.2, containing I% 2-mercap- 
toethanol, 100 mM EDTA was added and digestion with peptide N-glyco- 
hydrolase F (25 mU/precipitate; Boehringer Mannheim Biochemicais) was 
carried out overnight at room temperature.  Subsequently,  samples were 
separated by 6% SDS-PAGE and radioactive bands visualized by autora- 
diography. After exposure,  the three core protein bands (380, 360, and 260 
kD) were cut out and proteolysis of the gel slices with Staphylococcus 
aureus "r  protease (0.1-2/~g; Boehringer Mannheim Biochemicais) was 
performed according to Cleveland  et al. (1977) using 15% slab gels and 
SDS-PAGE.  The resulting peptides were then visualized by autoradiog- 
raphy. 
Western Blot Analysis 
For Western blot analysis,  total brains of 14-d-old NMRI mouse embryos 
(El4), and cerebrum and cerebellum of 1-, 5-, 8-, and 15-d-old (Pl, PS, P8, 
and PI5) and adult (older than 6 wk) NMRI mice were used. Tissue extracts 
were prepared by homogenization  in 50 mM Tris-acetate,  pH 8.0 (1 rni per 
gram wet weight of tissue), containing trypsin inhibitors from soybean aM 
turkey egg white (10 #g/mi each) and iodoacetamide (0.1 raM). As shown 
previously  (Streit et al.,  1990) buffers containing detergents  or chaotropic 
agents were not necessary for optimal recovery  of the proteoglycan.  Ho- 
mogenates were shaken at 4~  for 1 h and centrifuged for 10 rain at 200 g 
and 4~  Protein concentrations  in the supernntant  were determined accord- 
ing to Bradford (1976).  In some cases homogenates were digested with 
choMroitinase ABC (Boehringer  Mannheim  Biochemicals; 20 mU per 100 
#g protein) for 5 h at 37~  Equal amounts of  pretein (100 #g per lane) were 
separated by SDS-PAGE on 6% slab gels followed by transfer to nitrocellu- 
lose filters  according to Kyhsc-AMersen (1984) as described previously 
(Streit et ai.,  1990).  Alkaline phosphatase coupled secondary antibodies 
(Dianova) or nsI Protein A (Amersham Corp.) were used for detection. 
Cell Culture 
Highly enriched cultures of GFAP-positive,  mature astrocytes were ob- 
tained from brains of 14- to 16-d-old mouse embryos (Trotter et al., 1989). 
Cells from 10 to 12 brains were plated into two T75 poly-L-lysine-conted 
tissue culture flasks in Eagle's Basal Medium containing 10% horse serum 
(culture medium). After 4 to 5 d in culture, neurons were removed by im- 
munocytolysis  with mAb M5 (Keilhaner et ai., 1985) and guinea pig com- 
plement. After another 5 d, loosely  attached macrophages were removed 
by gently  shaking the flasks.  Oligodendrocytes  and glial precursor cells 
were then removed by vigorously shaking the flasks for ,-15 s. The removal 
of ceils was followed microscopically.  The procedure resulted in confluent 
astrocyte monotayer cultures with a purity of ~176  % GFAP-positive cells. 
Astrocytes were maintained in culture medium for another 2 to 5 d before 
they were taken as single cell suspensions for the cell-to-substratum adhe- 
sion assays. Gliai precursor cells appearing during this period were shaken 
off immediately before the preparation of single cell suspensions.  Oligoden- 
drocytes  were prepared according to the procedure described above, har- 
vested by shaking and plated on poly-L-lysine-coated  Petri dishes. Purifica- 
tion of small cerebellar neurons from 6-d-old mice was  carried out as 
described (Kellhauer et ai., 1985). Astrocytes,  oligodendrocytes,  and neu- 
rons were metabolically labeled with [35S]methionine and processed for 
immunoprecipitation with polyclonai  antibodies to astrochondrin as de- 
scribed previously  (Streit et al.,  1990). 
Cerebellar  microexplant cultures  were  prepared  from  6-d-old  mice 
(Fischer et al.,  1986).  For antibody perturbation experiments,  Fab frag- 
ments of polyclonal antibodies to astrochondrin  were used at concentrations 
between 150-500 t~g/ml and monovalent IgM fragments of monoclonai [,5 
antibody at  100-300  #g/ml.  Fab fragments of polyclonal  antibodies to 
mouse liver membranes reacting with the cell surface of all cell types were 
used as control antibodies at the same concentrations. Antibodies were 
added to the cultures 4 or 16 h after seeding the microexplants onto cover- 
slips. 
Migration of granule cells in cerebellar folium explant cultures was de- 
termined as described by LiMner et al.  (1983,  1986) with the following 
modifications:  Premigratory proliferating ceils were labeled with bromode- 
oxyuridine (BrdU; Del Rio aM Soriano,  1989)  instead of labeling with 
[3H]thymidine.  Explants of cerebellar cortex folia from 10-d-old C57BL/ 
J6 mice were labeled in vitro with 5 mM BrdU (No. B 5200; Sigma Chemi- 
cal Co.) for 90 min in serum-fr~ defined culture medium. The explants 
were then washed thoroughly with defined medium and five to seven folia 
were maintained  for 3 d in 3 ml medium with or without addition of  antibod- 
ies. Frozen sections O0-~m  thick) were cut in sagittal orientation and fixed 
for 30 rain at room temperature in PBS, pH 7.3, containing 0.5% parafor- 
maldehyde.  The sections were processed at room temperature as follows: 
after several  washes  in PBS they were treated for 20 rain at room tem- 
perature with 4 N HCI in PBS containing 0.5% Tween 20 for denaturation 
of DNA and permeabilization, washed several times in PBS,  foLlowed by 
a 35-rain incubation step with mouse mAb against BrdU (Sigma Chemical 
Co.) diluted 1:100 in PBS containing 0.5% BSA and 0.5% Tween 20. After 
washing in PBS, sections were blocked with PBS containing 1% horse se- 
rum and 0.1% BSA (blocking buffer) for 10 rain, washed in PBS, incubated 
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1:100  in  blocking buffer,  and  finally  mounted in  PBS  containing 90% 
glycerol and 2 % Nal. The spatial distribution of BrdU-labeled cells was de- 
termined by automated image analysis using an IBAS system (Kontron; Karl 
Zeiss,  Oberkochen,  Germany)  (Husmann et al.,  1992).  Briefly,  micro- 
scopic images of the immunostained frozen sections of cerebellar folia were 
recorded with a video camera. For quantitative comparison of the distribu- 
tion patterns of labeled cells under various experimental conditions, the 
mean values of the distances of labeled cells (tzm from pial surface) of every 
histogram were calculated and designated as migratory index (MI). Inhibi- 
tion of cell migration was calculated as follows: 
% inhibition =  (MI [control]) -  (MI [experimental])/(MI[control]) ￿  100. 
For each experimental value, three independent experiments were carried 
out in triplicates. 
Cell-to-Substratum Adhesion Assay 
Collagen type IV, fibronectin, and laminin were each coated onto tissue cul- 
ture Petri dishes as single spots in a 2 ~1 droplet at a concentration of 20 
/~g/ml in HBSS overnight at 37~  in a CO2 incubator. The droplets were 
then removed by aspiration.  The Petri dish was blocked with 3%  heat- 
inactivated BSA in HBSS for 1 h at 37~  and afterwards washed three times 
with HBSS.  Astrocytes were harvested from cell monolayers after mild 
trypsin treatment (20/~g/ml trypsin, 0.2 % EDTA in HBSS for 5 min at room 
temperature), suspended in modified Sato medium (Trotter et al., 1989) in 
the presence or absence of antibodies and added to the test plates at a density 
of 2.5  ￿  105 cells/ml. For antibody perturbation experiments, Fab frag- 
ments of polyclonal antibodies to astrochondrin were used at concentrations 
between 125-500/~g/rnl. Fab fragments of polyclonal antibodies to mouse 
liver membranes reacting with the surface of  astrocytes were used as control 
antibodies  at  the  same  concentrations.  30  min  after plating,  the  non- 
attached cells were removed by washing twice with HBSS. The remaining 
cells were again incubated in Sato medium in the presence or absence of 
antibodies. The number of attached cells was evaluated by phase contrast 
microscopy after 5 h.  Cells were then further maintained in culture and 
fixed after 24 h in PBS containing 4 % paraformaldehyde for 10 min at room 
temperature and stained with 0.2% toluidine blue in 2.5%  Na2CO3.  Cell 
process formation  was  evaluated  microscopically:  cells  with  processes 
longer than two thirds of the cell diameter were counted as process bearing 
cells. Cells with round, flattened morphology (cf. Fig. 9f) and with trian- 
gular morphology (cf. Fig. 9 h) were counted as non-process bearing cells. 
The percentage of process bearing cells (between 50 and 80% of all adher- 
ent cells) in the absence of antibodies or in the presence of Fab fragments 
of antibodies to mouse liver membranes was set to 100% and inhibition of 
process formation in the presence of antibodies to astrochondrin was calcu- 
lated in relation to this value. 
lmmunocytochemistry 
Light Microscopy. Animals were sacrificed by cervical dislocation. Cere- 
bella were quickly frozen in isopentane cooled by liquid nitrogen. Cryosec- 
tions, 10-t~m thick, were mounted on poly-L-lysine-coated  glass coverslips 
and allowed to dry for at least 1 h at room temperature. Indirect immuno- 
fluorescence was carried out as described previously (Goridis et al., 1983). 
For immunocytology of cultured cerebellar microexplants, cultures were 
fixed and permeabilized in ice-cold 96% ethanol, and indirect immunofluo- 
rescence was carried out as described (Schnitzer and Schachner,  1981). 
Specificity of the immunoreaction was verified by incubation of sections or 
cultures with 1% BSA containing 0.1% horse serum instead of  primary anti- 
bodies. 
EM. Animals were deeply anaesthetized by imraperitoneal injection of 
3 % chloral hydrate (aqueous solution, 0.01 mg/g body weight) and perfused 
i  ntracardially with a solution of  4 % paraformaldehyde and 0.1% glutaralde- 
hyde in 0.12 M Palay buffer (Palay and Chan-Palay, 1974).  Cerebella were 
post-fixed in fixation solution without glutaraldehyde for "r  h at 4~  and 
embedded in 5% Agar-Agar (Difco Laboratories, Detroit, MI) diluted in 
PBS, pH 7.3. Sections, 50-70-/~m thick, were cut on a vibratome and rinsed 
for up to 2 h in PBS containing 0.1% BSA. Pre-embedding staining, using 
primary polyclonal antibodies and peroxidase-coupled protein A, was per- 
formed as described (Martini and Schachner, 1986; Nolte et al., 1989).  In 
brief, vibratome sections were incubated first in 0.1 M NalO4 (10 min) and 
then in 1% NaBI-I4 (15 min), and finally in 5% DMSO (30 min) at room 
temperature.  Sections were incubated with polyclonal antibodies to as- 
trochondrin overnight at 4~  washed, incubated with peroxidase-coupled 
protein A for at least 2 h at room temperature, and washed again. After fixa- 
tion with 0.1% glutaraldehyde for 15 rain, sections were immersed in 0.02 % 
3,3'-diaminobenzidine-4HCl (Sigma Chemical Co.) in 0.04 M Tris buffer, 
pH 7.6, for 30 min, then in the diaminobenzidine solution containing 0.01% 
H202,  also for 30 min, all at room temperature. Sections were post-fixed 
in 2 % OsO4,  dehydrated in acetone, and embedded in Spurr (Piano, Mar- 
burg, Germany). Ultrathin sections were analyzed by EM (EM 10C; Carl 
Zeiss). 
Solid Phase Radioligand Binding Assay 
Iodination of  purified astrochondrin was performed according to the method 
of Salacinski et al.  (1981) as described (Streit et al.,  1990).  Radioligand 
binding assays were also carried out as described (Fahrig et al.,  1987). 
Briefly,  individual  wells of flexible microtiter plates (No.  3911 Falcon, 
Cockeysville, MD) were incubated overnight at 4~  with different proteins 
at concentrations of 20 #g/ml in 0.1 M NaHCO3, pH 8.2 (coating buffer). 
Plates were then treated with coating buffer containing 1% BSA for 1 h at 
room temperature and afterwards washed three times with hypotonlc (10 
mM K2HPO4/KH2PO4,  15 mM NaC1,  1 mM EDTA, 0.1% BSA, pH 7.4) 
or isotonic incubation buffer (10 mM K2HPOjKH2PO4,  150 mM NaCI, 
1 mM EDTA, 0.1% BSA, pH 7.4).  For experiments carried out in the pres- 
ence of Ca  2+,  1 mM CaCI2 was added to the incubation buffers that con- 
tained no EDTA.  Wells were incubated with  125I-labeled astrochondrin 
(usually 50,000-70,000 cpm) diluted in the appropriate incubation buffer for 
4 to 5 h at room temperature and washed five times in incubation buffer. 
Bound radioactivity was counted immediately after cutting the bottom of 
the plastic wells. Coating efficiencies of the different proteins were deter- 
mined as described (Fahrig et al.,  1987) and found to be similar (,~i0% 
of the total input) for all collagen types and recognition molecules. Values 
of saturation curves in the binding assay were plotted according to Scatchard 
(1949)  and could be approximated with one linear function by linear re- 
gression. Binding of 125I-labeled astrochondrin to BSA (unspecific back- 
ground) was subtracted from experimental values unless indicated. 
When binding assays were carried out in the presence of glycosaminogly- 
cans or monosaccharides, these substances were mixed with 125I-labeled 
astrochondrin immediately before the assay at concentrations indicated in 
the figure legends. 
The percentage of maximal binding was determined as follows: maximal 
binding in each experiment was set to 100% and the other values calculated 
in relation to this value. Mean values of different experiments carried out 
in triplicates were calculated and are shown +SD. 
Results 
Relationship between the Three Core Proteins of the 
Condroitin Sulfate Proteoglycan 
We previously demonstrated that digestion with chondro- 
itinase ABC of the L5 carbohydrate expressing proteoglycan 
isolated from mouse brain generated three core proteins of 
different molecular size (Streit et al., 1990).  To distinguish 
whether these core proteins are structurally related to each 
other, proteolytic peptide maps were generated from biosyn- 
thetically labeled proteoglycan derived from astrocyte cell 
cultures (Fig. 2). After treatment with chondroitinase ABC 
and N-glycohydrolase F and digestion with V8 protease, the 
three core proteins yielded similar peptide maps. Whereas 
the peptide patterns of 260- and 360-kD core proteins were 
very similar, the 380-kD core protein not only yielded corre- 
sponding, but also different peptide bands. Three peptides 
with apparent molecular weights of •19,  17, and 7.5 kD were 
found to be identical in all the core proteins (Fig. 2, filled 
arrows). The 380-kD protein contained additionally one ma- 
jor peptide of ~ 30 kD (Fig. 2, lanes 3 and 4), also occurring 
as an intermediate product in digestion of the 360-kD mole- 
cule (Fig. 2, lane 6).  Moreover, the similarity between the 
different protein bands is underscored by the fact that 40.5- 
and 24-kD  fragments appear during digestion of both the 
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Immunoprecipitates  of astrochondrin  with polyclonal antibodies 
from 35S-labeled cultures  of immature astrocytes were digested 
with chondroitinase ABC and peptide N-glycohydrolase  E The in- 
set shows the pattern of the deglycosylated core proteins in 6% 
SDS-PAGE. Numbers refer to the molecular  weights of protein 
bands after chondroitinase treatment only as originally described 
in Streit et al. (1990). Proteolytic digestion of the deglycosylated 
380 kD (lanes 1-4), 360 kD (lanes 5-8) and 260 kD (lanes 9-12) 
components was carried out with 0.1 #g (lanes 2, 6, and 10), 1 l~g 
(lanes 3, 7, and 11) and 2/~g (lanes 4, 8, and 12) V8 protease. Lanes 
1, 5, and 9 show the core proteins before treatment with V8 pro- 
tease. Filled arrows mark peptides identical in all three core pro- 
teins, open arrows those which are similar in the 360- and 260-kD 
proteins only. Molecular weights of two different standard protein 
mixtures are indicated at the left margin. 
380- and the 360-kD core proteins (Fig. 2, lanes 3 and 6). 
The peptides with the apparent molecular weights of rvl0, 
12, and 22.5 kD (Fig. 2, open arrows) derived from the 360- 
and  260-kD  components were not present in the  380-kD 
component.  Thus,  the  three  proteins  show  considerable 
similarities  in  their proteolytic peptides and appear to be 
comprised of closely related molecules for which we pro- 
pose the name of astrochondrin, reflecting its unique local- 
ization on astrocyte cell surfaces and the presence of chon- 
droitin sulfate as glycosaminoglycan component. It is worth 
emphasizing here that in accordance with our previous ob- 
servations (Streit et al., 1990) immunofluorescence labeling 
of  cerebellar cell cultures (not shown) and immunoprecipita- 
tion of  biosynthetically labeled cultures of  purified small cer- 
ebellar  neurons,  astrocytes,  and  oligodendrocytes  using 
polyclonal antibodies to astrochondrin demonstrated that the 
proteoglycan is expressed by astrocytes only (Fig.  1 C). 
Immunochemical and Immunocytochemical Detection 
of  Astrochondrin during Development 
To gain first insights into the role of  astrochondrin in the cen- 
tral nervous system, its expression at different developmental 
stages was investigated immunochemically and immunocy- 
tochemically. Western blot analysis of  crude homogenates of 
murine cerebellum and cerebrum of different developmental 
stages  (from embryonic day  14 until adult;  Fig.  3)  using 
polyclonal antibodies to astrochondrin showed that at em- 
bryonic day  14,  astrochondrin was hardly detectable. As- 
trochondrin expression increased during the first postnatal 
week,  with a  peak at  approximately day  8,  and  then de- 
creased  to  low  levels  in  the  adult.  At  all  developmental 
stages, expression of astrochondrin was more prominent in 
Figure 3. Western blot analysis of astrochondrin expression during 
development in crude homoganates of cerebellum (/), cerebrum 
(2), or total embryonic brain (E/4).  Homogenates were prepared 
from 14-d-old mouse embryos (E/4),  1 (P1), 5 (PS), 8 (PS), and 
15 (P15)-d-old  and adult (A) mice and assayed with polyclonal anti- 
bodies to astrochondrin. Molecular weight markers are indicated 
at the right margin. 
the cerebellum than in the cerebrum. Identical results were 
obtained with monoclonal L5 antibody (not shown). 
Immtmoprecipitations with polyclonal antibodies to as- 
trochondrin from detergent lysates of biosynthetically la- 
beled immatm'e and mature astrocytes (not shown) demon- 
strated that all three core proteins are present in both cell 
populations suggesting that no major changes in the expres- 
sion of the core proteins occur during development. 
To investigate the cellular and subcellular localization of 
astrochondrin  in  situ,  immunocytochemical studies  were 
carded out in histological sections of postnatal mouse cere- 
bellum at the light and electron microscopic level. Indirect 
immunofluorescence was  performed with monoclonal L5 
antibody and polyclonal antibodies to astrochondrin on fresh 
frozen sections of 6- and 14-d-old adult mice (not shown). 
Both antibodies showed almost identical staining patterns at 
these stages. In agreement with the immunochemical data, 
the most distinct and highest immunoreactivity was observed 
at postnatal day 6. At this stage, the antibodies reacted most 
prominently with the developing molecular layer in a homo- 
geneous distribution. Immunoreactivities for both antibod- 
ies were also detectable in the external and internal granular 
layers, with the latter being more intensely stained by the an- 
tibodies than the external granular layer. The internal granu- 
lar layer showed labeling around granule cell bodies.  The 
staining pattern was often punctate in the outer margin of  the 
external granular layer. At day 14, immunoreactivity  became 
very weak in the molecular layer when compared to earlier 
stages and was hardly or not at all detectable in the adult 
cerebellum. In the adult, only the internal granular layer and 
the white matter were very weakly labeled with both anti- 
bodies. 
Immunoelectron microscopic  analysis  using  polyclonal 
antibodies  to  astrochondrin  in  the  cerebellum of 6-d-old 
mice showed immunoreactivity at the cell surface of astro- 
cytes including those of the radial Bergmann glial processes 
in the external granular and molecular layers (Fig. 4, A and 
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croscopic  localization of as- 
trochondrin  in  the  cerebel- 
lar  cortex  of  6-d-old  mice 
using  polyclonal  antibodies. 
(A)  External  granular  layer. 
Bergrnarm  glial fibers (Bg) are 
positive  for astrochondrin  at 
contact sites with each other 
and  with  granule  cells  (g), 
(solid  arrowheads).  Contact 
sites  between  granule  cell 
bodies and their axonai pro- 
cesses do not show detectable 
levels  of  immunoreactivity 
(empty arrowheads).  (B) Ex- 
ternal  granular  layer. Astro- 
cytic endfeet (as) abutting onto 
the basement membrane (bin) 
at the pial surface are weakly 
antigen-positive (solid arrow- 
heads).  The basement mem- 
brane  itself  does  not  show 
detectable levels of immuno- 
reactivity (empty  arrowheads). 
(C) Molecular layer. The cell 
surfaces of parallel fibers are 
immunoreactive (solid arrow- 
heads),  whereas contact sites 
between dendrites (d) appear 
negative (empty arrowheads). 
Bergmann glia fibers (Bg) ex- 
press the proteoglycan at con- 
tact sites (solid arrowheads). 
Bars, 0.2 #m. 
C). Endfeet of astrocytes contacting blood vessels or endfeet 
of Bergmann  glia  abutting  onto  the  pia  mater  were  as- 
trochondrin positive (Fig. 4 B). The basal lamina juxtaposed 
between glial endfeet and pia did not show detectable im- 
munoreactivity  (Fig.  4  B).  Within  the  external  granular 
layer, astrochondrin was not detectable on somata or proces- 
ses of granule cells where then contacted each other (Fig. 4 
A, empty arrowheads). Contact sites between granule cells 
and Bergmann glial processes, however, were astrochondrin 
positive (Fig. 4 A, solid arrowheads). In agreement with the 
observations at the light microscopic level strong immunore- 
activity in the molecular layer was seen at the cell surface 
of parallel fibers (Fig. 4  C).  In the molecular and internal 
granular layers, astrochondrin was detectable at the surface 
of neurons only where they were contacted by an astrocytic 
process or by the astrochondrin-positive parallel fibers (Fig. 
4, A and C). In the adult cerebeUar cortex, hardly any im- 
munoreactivity was observed by immuno EM neither in as- 
sociation with the surface nor intracellularly. 
Astrochondrin Is Involved in Cerebellar 
Granule Cell Migration 
To gain insights into the functional roles of astrochondrin in 
the early postnatal morphogenesis of the cerebellar cortex, 
antibody perturbation experiments were performed in differ- 
ent cell culture systems. Since astrochondrin was most prom- 
inently  expressed  in  the  cerebellum  and  its  expression 
peaked at the beginning of  the second postnatal week, the de- 
velopmental stage at which cerebellar granule cell migration 
along  astrochondrin-positive Bergmann  glial  fibers  takes 
place, we first tested whether astrochondrin may be involved 
in this migration process. In tissue pieces of 10-d-old mouse 
cerebellum maintained in vitro for 3 d,  the dislocation of 
bromodeoxyuridine-labeled  neurons from the external to the 
internal granular layer can be determined quantitatively. In 
this assay system, the IgG fraction of polyclonal antibodies 
to astrochondrin inhibited granule cell migration by 28  + 
6.7%  (Figs.  5  and 6).  This value has previously been ob- 
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antibodies  to  astrochondrin 
on the migration of cerebellar 
granule cells. Sagittal sections 
of cerebellar folium explants 
were  immunocytochemically 
stained  with  antibodies  to 
bromodeoxyuridine  used  to 
poise-label dividing cells. (A) 
Explant maintained in the ab- 
sence of antibodies. (B) Ex- 
plant maintained in the pres- 
ence of polyclonal antibodies 
to  astrochondrin  (IgG  frac- 
tion, 500 #g/ml). (C) Explant 
maintained in the presence of 
monoclonal antibody 412  to 
the  L2 carbohydrate epitope 
(IgG  fraction,  500  /~g/ml). 
Bar, 50/~m. 
served with polyclonal antibodies to L1 (both IgG fraction 
and Fab fragments). No inhibition was observed when ex- 
plants were maintained in the presence of monoclonai anti- 
body 412  to  the  L2/HNK-1  carbohydrate structure  (IgG 
fraction). 
Astrochondrin Is Involved in Astrocytic 
Process Formation 
Astrocyte Outgrowth in CerebeUar Microexplant Cultures. 
Since Bergmann glial cells continue to divide and elaborate 
radially oriented processes abutting with their endfeet onto 
the meninges early postnatally, the question arose whether 
astrochondrin is involved in astrocyte-mediated cell interac- 
tions other than cerebellar granule cell migration. Thus, the 
cellular outgrowth pattern of cultured microexplants from 
early postnatal mouse cerebellum was investigated in the ab- 
sence and presence of polyclonal antibodies to astrochondrin 
and monoclonal L5 antibodies. These microexplant cultures 
provide an in vitro assay system to monitor migration of cell 
bodies and process outgrowth of neurons and astrocytes. 
When  microexplants were plated  onto glass  coverslips 
coated with poly-D-lysine, the characteristic outgrowth pat- 
tern described by Fischer et al.  (1986) could be observed. 
Microexplants attached to the substratum within the first 2 h. 
Neurites started to leave the explant after 24 h. Neuronal cell 
bodies migrated out of the explant core and neurites began 
to fasciculate in the periphery after 48-72 h. Astrocytes sent 
out processes more slowly than neurons and rarely left the 
explant core. When Fab fragments of polyclonal antibodies 
to astrochondrin (250/~g/ml)  or monovalent fragments of 
polyclonai  antibodies  to  astrochondrin  (250  #g/mi)  or 
monovalent fragments of the monoclonal L5 antibody (300 
#g/ml) were added to the cultures 16 h after plating, the out- 
growth  of astrocytic processes was  found to be modified 
(Fig. 7), as visualized by immunocytochemical staining with 
antibodies to GFAP, a marker for mature astrocytes. Forma- 
tion of processes was markedly reduced (Fig. 7, b, e, c, and 
f) when compared to the controls, in which either no anti- 
bodies or Fab fragments of polyclonal antibodies to mouse 
liver membranes (250 #g/ml) had been added (Fig. 7, a and 
d).  Furthermore, •20%  of all explants maintained in the 
presence of antibodies to astrochondrin or monoclonai L5 
antibody showed strong fasciculation of neurites in the vicin- 
ity of the explant core (Fig.  7 c). 
When microexplants were plated on coverslips coated with 
laminin, the outgrowth of neurites and astrocytes as well as 
their migration out of the explant core were enhanced in time 
and space when compared to poly-D-lysine as substratum. 
Therefore, Fab  fragments of polyclonal antibodies  to  as- 
trochondrin or mouse liver membranes and monovalent frag- 
ments of monoclonal L5 antibody were added to the cultures 
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Figure 6. Relative distribution of  bromodeoxyuridine pulse-labeled 
cells with respect to their distance from the pial surface. Cerebellar 
folium explants pulse labeled with bromodeoxyuridine were main- 
tained for 3 d in vitro in the absence (weak  line) or presence (solid 
line) of polyclonal antibodies to astrochondrin. The position of the 
bromodeoxyuridine-labeled cells in sagittal sections is plotted as a 
function of distance from the pial surface (in #m). In the presence 
of  antibodies to astrochondrin (IgG fraction, 500 #g/ml), migration 
of pulse-labeled cells was inhibited by 28 + 6.7% when compared 
with controls. The histogram shows mean values of three indepen- 
dent experiments carried out in triplicate. EGL, external granular 
layer; IGL, internal granular layer; ML, molecular layer; N, num- 
ber of labeled cells expressed in percentage. 
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L5  antibody  and  polyclonal 
antibodies  to  astrochondrin 
on the outgrowth pattern ofas- 
trocytes in cultures of  cerebel- 
lax microexplants on poly-o- 
lysine.  Microexplants  from 
cerebella of  6-d-old mice were 
plated on poly-o-lysine-coated 
coverslips. Fab fragments of 
polyclonal  antibodies  to mouse 
liver  membranes  (a  and  d; 
500 t~g/ml) or to astrochon- 
drin (b and e; 250 #g/ml) or 
monovalent IgM fragments of 
monoclonal  L5  antibody  (c 
and  f; 300/~g/ml) were added 
16 h later. After 72 h in vi- 
tro, explants were stained by 
indirect  immunofluorescence 
with antibodies to GFAP to vi- 
sualize mature astrocytes, a-c 
show  corresponding  phase 
contrast micrographs to fluo- 
rescence images d-f, respec- 
tively. Bar, 50 #m. 
already  4  h  after plating.  After 48  h  of culture,  GFAP- 
positive astrocytes were monitored in their outgrowth pat- 
tern (Fig. 8). As on poly-o-lysine, monoclonal L5 antibody 
and polyclonai antibodies to astrochondrin reduced the for- 
marion of astrocytic processes, whereas they did not inter- 
fere with neurite outgrowth or migration of neuronal cell 
bodies. 
The outgrowth pattern of microexplants plated on mono- 
layers of mature astrocytes as substratum closely resembled 
that observed on laminin. Addition of monoclonal L5 anti- 
body and polyclonal antibodies to astroehondrin 4  h  after 
plating did not reveal an altered pattern of neurite outgrowth 
after 48 h as visualized immunocytochemicaUy by antibod- 
ies to the neural recognition molecule L1 (not shown). The 
outgrowth pattern of astrocytes could not be monitored in 
these cultures, since explant-derived astrocytes could not be 
distinguished  immunocytochemically  from  the  astrocyte 
monolayer underneath. 
These observations indicate that both monoclonal L5 anti- 
body and polyclonal antibodies to astrochondrin interfere 
with the outgrowth pattern of astrocytes in cerebellar micro- 
explant cultures suggesting that astrochondrin and the L5 
carbohydrate domain may be involved in formation of astro- 
cytic processes.  On  astrocyte surfaces astrochondrin rep- 
resents the only L5-expressing molecule so the target of both 
polyclonal and monoclonal antibodies is  the proteoglycan 
only. Since neurons achieve L5-positivity only after several 
days in culture and do not express astrochindrin in vitro, 
modification in neurite outgrowth pattern in the presence of 
the antibodies may thus be secondary to the inhibition of as- 
trocyte outgrowth. 
Astrocyte Adhesion and Process Formation. We next in- 
vestigated  the  influence  of  polyclonal  antibodies  to  as- 
trochondrin on astrocyte adhesion and process outgrowth in 
cell-to-substratum adhesion assays. As substrata, fibronec- 
tin, laminin, collagen type IV, and astrochondrin were cho- 
sen and coated on tissue culture Petri dishes as individual 
spots. Mildly trypsinized single cell suspensions of mature 
astrocytes expressing astrochondrin at the cell surface were 
plated onto these substrates in the absence or presence of  Fab 
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nal L5 antibody and polyclo- 
nal  antibodies  to  astrochon- 
drin on the outgrowth pattern 
of astroeytes  in  cultures  of 
cerebellar  microexplants  on 
laminin.  Microexplants from 
cerebella of  6-d-old mice were 
plated  on  coverslips  coated 
with  20 #g/ml  laminin.  Fab 
fragments of polyclonal anti- 
bodies to mouse liver mem- 
branes (a and d; 500 #g/ml) 
or to astrochondrin (b and e; 
250  #g/ml)  or  monovalent 
IgM fragments of monoclonal 
L5 antibody (c and  f; 300 #g/ 
ml) were added 4 h later. Af- 
ter 48 h in vitro, explants were 
stained  by indirect  immuno- 
fluorescence  with  antibodies 
to GFAP to visualize mature 
astrocytes,  a-c  show  corre- 
sponding phase  contrast  mi- 
crographs to fluorescence im- 
ages  d-f,  respectively.  Bar, 
50 ~m. 
fragments (250 #g/ml) of  polyclonal antibodies to astrochon- 
drin or mouse liver membranes. Cell adhesion and process 
formation were evaluated after 5  and 24 h.  Astrocytes at- 
tached well to laminin,  fibronectin and  collagen type IV 
within 30 to 45 min, whereas astrochondrin itself proved to 
be a very poor substratum and almost no cells adhered. Anti- 
bodies  to  astrochondrin did  not  interfere with  the initial 
adhesion of astrocytes to any of these substrata. 
After 5 h in culture, astrocytes had begun to extend pro- 
cesses almost equally well on the three substrata in the ab- 
sence or presence of antibodies to mouse liver membranes 
(Fig. 9, a and c, for collagen type IV) and formed a network 
of processes after 24 hours (Fig. 9, e, g, and i, for collagen 
type IV, laminin and fibronectin, respectively). In the pres- 
ence of polyclonal antibodies to astrochondrin,  astrocytes 
remained without processes 5 h after plating (Fig. 9, b and 
d, for collagen type IV) and, after 24 h, hardly formed any 
processes but showed a round, somewhat flattened morphol- 
ogy on collagen type IV (Fig. 9f) and a triangular morphol- 
ogy on laminin (Fig. 9 h). Formation of cell processes was 
markedly reduced on both substrata in the presence of anti- 
bodies  to  astrochondrin,  with  the  inhibition  being  more 
prominent on collagen type IV  (•80%)  than on laminin 
(ru40 %) (Fig.  10 A). The extent of inhibition of process for- 
mation depended on the antibody concentration (Fig. 10 B). 
When fibronectin was used as substratum, no differences in 
morphology could be observed between astrocytes cultured 
in the presence or absence of polyclonal antibodies to liver 
membranes or to astrochondrin (Figs. 8, i and j  and 10 A). 
These observations indicate that astrochondrin may be in- 
volved in the formation of  astrocytic processes by interaction 
with the extracellular matrix components laminin and colla- 
gen, but not fibronectin. 
Binding of  Astrochondrin to ExtraceUular 
Matrix Components 
Since these cell biological studies suggested that astrochon- 
drin  interacts with particular extracellular matrix compo- 
nents we addressed the question, whether the purified mole- 
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cess formation of mature astrocytes on the substrata laminin, colla- 
gen type IV, and fibronectin. Collagen type IV (a-f), laminin (g 
and h), and fibronectin (i and j) were coated onto Petri dishes as 
individual spots and single cell suspensions of mature astrocytes 
were added in the presence of Fab fragments of polyclonal antibod- 
ies to mouse liver membranes (a, c, e, g, and i) or to astrochondrin 
(b, d, f, h, and j). Astrocyte morphology was evaluated either 5 h 
(a-d) or 24 h (e-j) after plating the cells. Cells were either immu- 
nocytochemically labeled with antibodies to GFAP (c and d) or 
stained with toluidine blue (a, b, and e-j). Bars, 50 #m. 
cule could directly bind to these components in a solid phase 
radioligand binding assay.  Under hypotonic conditions (10 
mM phosphate buffer,  15 mM NaC1,  1 mM EDTA, 0.1% 
BSA, pH 7.4) astrochondrin could be shown to interact with 
collagen types I, II, III, IV, V, IX, and G, and laminin (Fig. 
11 A) with different efficiencies, but not with collagen type 
VI and BSA. Interaction was most pronounced with collagen 
types III and V, with up to 40 4- 5 % of the added astrochon- 
drin being bound. Astrochondrin bound 30- to 40-fold more 
efficiently to the collagens type HI and type V than to BSA. 
When  the proteoglycan concentration was  reduced (from 
70,000 to ~10,000 cpm) binding of up to 80% of the total 
input and a 50- to 60-fold better binding to collagens type 
III and V than to BSA was found, suggesting that not only 
a subset of molecules, but all components of astrochondrin 
are  able  to  interact  with  these  collagens.  Binding  of as- 
trochondrin to collagen types IV  or IX  and  laminin was 
stronger in the presence of 1 mM Ca  2+ (10 mM phosphate 
buffer,  15  mM  NaCI,  1 mM  CaC12, 0.1%  BSA,  pH 7.4) 
than in its absence. Under these conditions, astrochondrin 
bound up to sevenfold better to collagen types IV and IX 
("o30%  of the total  input)  and  3.5-fold better to laminin 
(~15% of the total input) than to BSA. These results indi- 
cate that divalent cations are promoting the interactions be- 
tween astrochondrin and collagen types IV and IX or lami- 
nin.  Binding of astrochondrin to  the other collagens was 
not markedly different in the presence or absence of Ca  2+ 
(Fig.  11 B). 
Under isotonic conditions (10 mM phosphate buffer, 150 
mM NaC1,  1 mM EDTA, 0.1% BSA, pH 7.4) binding ofas- 
trochondrin to extracellular matrix components was gener- 
ally reduced, remaining pronounced for collagen types 1II 
and V with 7-12% of the input being bound (,,ol0-fold above 
binding to BSA;  Fig.  11  C).  Considerable binding of as- 
trochondrin to laminin and collagen type IV under isotonic 
conditions could only be observed in the presence of 1 mM 
Ca  2+ (10 mM phosphate buffer, 150 mM NaC1,  1 mM Ca  2+, 
0.1% BSA, pH 7.4;  Fig.  11 D) with values being approxi- 
mately  five-  to  sevenfold  higher  than  binding  to  BSA 
(3.5-5%  of the total input).  Under none of the conditions 
tested, astrochondrin was found to bind to the adhesion mol- 
ecules L1, N-CAM, MAG and AMOG and to the extracellu- 
lar matrix components J1/tenascin, J1-160/180, and fibronec- 
tin (Fig.  11, A-D). 
To analyze the specificity of the interaction between as- 
trochondrin and collagen types 11/and V, increasing amounts 
of astrochondrin were allowed to bind to hypotonic (Fig. 12) 
and  isotonic  (not shown) buffers.  Under both conditions, 
saturation could be achieved, suggesting a specific and finite 
number of proteoglycan binding sites. Scatchard plot analy- 
sis (Scatchard, 1949) of these data (Fig. 12, A and B, insets) 
yielded linear plots for collagen types HI (r =  0.94) and V 
(r  =  0.93) indicating that these collagens contain a  single 
class of binding sites for astrochondrin. 
To investigate whether the binding of astrochondrin to col- 
lagen types III and V is dependent on ionic interactions, the 
influence of different concentrations  of NaC1  on binding 
efficiencies was determined (Fig.  13).  Binding was highest 
at 15 mM NaC1 in 10 mM phosphate buffer, 1 mM EDTA, 
0.1% BSA, pH 7.4 (30% of the total input of astrochondrin), 
decreasing to a constant level of 5 to 7 % of the total input 
at 75 mM NaC1 in the same buffer. 
To further characterize the properties of the collagen bind- 
ing site, we studied the effect of polyanionic carbohydrates 
and charged monosaccharides on the binding of astrochon- 
drin to collagen (Fig. 14). Collagen types HI and V were in- 
cubated with  ~2q-labeled  astrochondrin in the presence of 
increasing concentrations of glucose-6-phosphate (10-7-10  -3 
M), neuraminic acid (10-7-10  -2 M), hyaluronic acid (1-3  x 
109 ng/ml),  dextran sulfate (10-1~  -~ M),  heparin (10  -~~ 
10  -3  M),  and  chondroitin  sulfate  (10-1~  -3  M)  (10  mM 
phosphate buffer, 15 mM NaC1,  1 mM EDTA, 0.1% BSA, 
pH 7.4). Glucose-6-phosphate, neuraminic acid, and hyal- 
uronic acid did not alter the binding of astrochondrin to all 
collagen types tested (not shown), whereas dextran sulfate, 
heparin and chondroitin sulfate were potent inhibitors (Fig. 
14, A and B). At half maximal binding, the astrochondrin- 
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evaluation of the effects of Fab 
fragments  of polyclonal anti- 
bodies  to astrochondrin (250 
#g/ml)  on process  formation 
by astrocytes on collagen IV, 
laminin  and  fibronectin  as 
shown in Fig.  9. The percent- 
age of process bearing ceils in 
control experiments was set to 
100%.  Bars  represent  mean 
values  of  three  independent 
experiments carried out in du- 
plicates  •  SD.  (B) Inhibition 
of  astrocytic  process  forma- 
tion as a function of concentration of Fab fragments of polyclonal antibodies to astrochondrin. Mean values from one representative experi- 
ment carried out in duplicates are given. In three independent experiments, SDs were <5 %. ([]) Collagen IV; ([]) laminin; ([]) fibronectin; 
(o)  collagen IV;  (~7) laminin. 
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collagen type III interaction was inhibited  ~30  times better 
by  dextran  sulfate  than by  chondroitin  sulfate  and heparin 
(Fig.  14 A).  In contrast,  when binding  of astrochondrin  to 
collagen  type  V  was  measured,  concentrations  of all three 
polyanions  were  similar  at  half maximal  inhibition  values 
with  chondroitin  sulfate  and heparin being  two-  to fivefold 
more potent  inhibitors  than dextran  sulfate. 
Discussion 
In this  study  we present  evidence  that the differently  sized 
core  proteins  of  the  astrocyte-derived  chondroitin  sulfate 
proteoglycan  (Streit et al.,  1990)  are structurally  related  to 
each other. At the moment we cannot distinguish whether the 
three components are generated by posttranslational modifi- 
cations or whether they are transcribed  from different mes- 
senger RNAs.  Furthermore,  pulse chase experiments  ruled 
out the possibility  that the two lower molecular weight pro- 
teins are derived by proteolytic cleavage of the 380-kD  com- 
ponent  (Streit,  A.,  and  M.  Schachner,  unpublished  obser- 
vations).  Since  the  peptide  maps  were  generated  from 
deglycosylated astrochondrin, it does not seem likely that the 
core  proteins  represent  differentially  N-glycosylated  forms 
of a single protein backbone (see also Streit et al.,  1990).  Be- 
cause of the characteristic expression of the proteoglycan by 
astrocytes  and  the  structural  similarities  between  the  in- 
dividual  core  components,  we  propose  to  designate  this 
Figure 11. Binding of astrochondrin to extracellular matrix compo- 
nents and neural recognition molecules as determined by the solid 
phase radioligand binding assay.  The interaction of ~25I-labeled as- 
trochondrin with collagen types  I  (I),  II  (lI),  III (IIl),  IV (/V), 
V  (V),  VI  (VI),  IX  (/X),  and  G  (G),  the  extracellular  matrix 
components laminin (L),  fibronectin (F),  J1/tenascin  (T),  and J1- 
160 (J1) and the neural recognition molecules L1 (L/), MAG (M), 
N-CAM (N), and AMOG (A) was investigated in hypotonic (15 mM 
NaCl; A and B)  and isotonic (150 mM NaC1;  C and D)  10 mM 
phosphate buffer, pH 7.4, in the presence (1 mM CaC12; B and D) 
or absence  (1  mM  EDTA;  A  and  C)  of Ca  2+.  Mean  values  are 
from three (C and D) and four (A and B) independent experiments 
carried out in triplicates  •  SD. In each experiment maximal bind- 
ing was set to 100%.  Binding of ~25I-labeled astrochondrin to BSA 
(B)  was not subtracted. 
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Figure 12.  Binding of astro- 
chondrin to collagen types III 
(A) and V (B) as a function of 
astrochondrin  concentration 
under  hypotonic  conditions 
(see legend to Fig. 9) as de- 
termined by the solid phase ra- 
dioligand binding assay. Mean 
values from one representative 
experiment carried out in trip- 
licates  +  SD are given. Or- 
dinate: Amount of |2SI-labeled 
astrochondrin  (cpm)  bound. 
Abscissa: input of t2SI-labeled 
astrochondrin (cpm). (Insets) 
Corresponding  Scatchard 
plots. 
group  of  chondroitin  sulfate  carrying  molecules  astro- 
chondrin. 
Astrochondrin,  expressed and released by astrocytes in 
vitro and associated with their cell surface (Streit et al., 
1990), is involved in granule cell migration and the interac- 
tion of astrocytes with certain extracellular matrix compo- 
nents. In particular, process formation on the extracellular 
matrix  substrata  laminin  and  collagen  type  IV,  but  not 
fibronectin, is influenced by antibodies to astrochondrin in 
vitro. In cerebellar microexplant cultures, antibodies to as- 
trochondrin interfered with  astrocytic process formation, 
whereas they did not affect neurite outgrowth patterns on 
different substrata.  In a  cell-to-substratum adhesion assay 
antibodies to astrochondrin inhibited process formation of 
astrocytes. 
To our knowledge, astrochondrin is the first nervous sys- 
tem-derived chondroitin sulfate proteoglycan shown to be 
involved in astrocyte process formation. It is noteworthy that 
astrochondrin does not mediate the initial attachment of as- 
trocytes to laminin or collagen type IV. Thus, adhesion and 
process outgrowth can be separated into two distinct events 
suggesting that distinct molecular mechanisms are involved. 
It is interesting in this context that a fibroblast derived hepa- 
ran sulfate proteoglycan was shown to be essential to induce 
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Figure 13. Binding of astrochondrin to collagen types III and V as 
a  function of NaCI concentration in  10 mM phosphate  buffer, 
1 mM EDTA, 0.1% BSA, pH 7.4, as measured by the solid phase 
radioligand binding assay. Mean values of two independent experi- 
ments carried out in triplicates +  SD are given. (D) Collagen III; 
(o) collagen V. 
formation of focal contact points, but not to initiate cell at- 
tachment in vitro (Woods et al., 1986). At the moment how 
astrochondrin affects astrocyte process outgrowth is still un- 
clear. Located on their cell surface it could help to stabilize 
cell-substrate contact by interacting with the respective ex- 
tracellular matrix components.  Also,  astroehondrin might 
interact with cell surface molecules, such as receptors for ex- 
traceUular  matrix  constituents,  thereby  modulating  their 
functional activities. On collagen type IV, astrochondrin ap- 
pears to be the predominant mediator of astrocyte process 
outgrowth, since outgrowth is almost completely inhibited 
by astrochondrin antibodies. The fact that process formation 
is only partly inhibited by astrochondrin antibodies when 
cells are maintained on laminin might reflect the fact that as- 
trocytes use more than one mechanism for process outgrowth 
on this  substrate,  only one of which is dependent on as- 
trochondrin. 
In  agreement  with  our  observations  on  the  functional 
properties of astrochondrin, binding of astrochondrin to col- 
lagen type IV and laminin, but not to the extracellular matrix 
component fibronectin could be observed under hypotonic 
and isotonic conditions. This interaction was promoted in 
the presence of Ca  2+. Since the interaction of astrochondrin 
with collagen types III and V  was least susceptible to the 
different binding conditions, this interaction was  studied in 
more detail and shown to be specific: both collagens show 
a  single, saturable class of binding sites for astrochondrin 
which  can  be  competed by  excess  of astrochondrin  (A. 
Streit, unpublished observations). Binding of astrochondrin 
to collagen types III and V  was diminished by increasing 
ionic strength suggesting that it partly depends on ionic inter- 
actions. Such interactions were shown to be crucial for bind- 
ing of glycosaminoglycans to collagens (Lindahl and H66k, 
1978; H66k et al.,  1984; Ruoslahti,  1988). It appears that 
the extent and pattern of sulfation of the glycosarninoglycan 
moiety does not play an important role in astrochondrin- 
collagen interactions as has been suggested for other proteo- 
glycan-collagen interactions (e.g., Koda et al., 1984; for re- 
view see Ruoslahti, 1988). In our study, chondroitin sulfate 
and heparin are approximately equally potent competitors 
for the interaction of astrochondrin with both collagens, al- 
though heparin contains clusters of highly sulfated regions, 
which potentially occur also in dextran sulfate (see Koda et 
al.,  1984),  while sulfate groups are more uniformly dis- 
tributed  along  chondroitin  sulfate  (Lindahl  and  H66k, 
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Figure 14.  Binding of astro- 
chondrin to collagen types III 
(.4) and V (B) in the presence 
of heparin,  chondroitin  sul- 
fate, and  dextran  sulfate as 
determined by the solid phase 
radioligand binding assay in 
10 mM phosphate buffer, pH 
7.4, containing 15 mM NaC1 
and I mM EDTA. Mean  values 
from triplicate measurements 
of one representative experi- 
ment are given; maximal  bind- 
ing was set to 100% and other 
binding efticiencies  calculated 
in relation to this value. Standard deviation for each value was less than 3% of maximal binding. Ordinate: % maximal binding of the 
u~I-labeled astrochondrin. Abscissa: concentration of polysaccharides incubated with astrochondrin before addition to the substrata. (o) 
Heparin; (o) chondroitin sulfate; (~7) dextran sulfate. 
1987).  Collagens have been  reported  to  contain specific 
binding sites which are selective for polysaccharides with 
regions of extensive sulfation interrupted by non- or low- 
sulfated regions (Lindahl and H66k, 1978). Chondroitin sul- 
fate chains apparently use different  binding sites on collagens 
(H66k et al., 1984; Lindahl and H66k, 1978). It is therefore 
possible that inhibition of astrochondrin-collagen interac- 
tions by heparin and dextran sulfate is due to steric hindrance 
rather than to competition for specific binding sites. The na- 
ture of the interaction of astrochondrin with laminin is not 
yet known.  Several  heparin  binding  sites  have  been  de- 
scribed for laminin (for review see Martin and Timpl, 1987), 
but it is not clear whether also chondroitin sulfate or chon- 
droitin sulfate proteoglycans use these or other sites. 
The relation of astrochondrin to other chondroitin sulfate 
proteoglycans in the nervous system (Hoffman and Edelman, 
1987; Stallcup  and Beasley,  1987; Faissner et al.,  1991; 
Zaremba et al., 1989; Margolis and Margolis, 1989; Oohira 
et al., 1989; Herndon and Lander, 1990) is not known. It is 
possible that astrochondrin constitutes a  subpopulation of 
proteoglycans from rat brain (Margolis et al., 1976; Gowda 
et al., 1989),  since both carry the L2/HNK-1 and L5 carbo- 
hydrate epitopes (Margolis, R. U., A. Streit, and M. Schach- 
ner, unpublished observations; Streit et al., 1990).  Further- 
more, subpopulations of the glia-derived chondroitin/dermatan 
sulfate proteoglycan syneuran (Faissner, A., A. Lochter, A. 
Streit, and M. Schachner, manuscript submitted for publica- 
tion) and astrochondrin share the L5 carbohydrate and the 
dermatan sulfate epitope DS-1 (Faissner, A., A. Streit, and 
M.  Schachner, unpublished observations). Whereas astro- 
chondrin is expressed by cultured astrocytes, the cytotactin 
binding (CTB) proteoglycan (Hoffman and Edelman, 1987; 
Hoffman et al.,  1988)  is expressed by neurons.  Since as- 
trochondrin could  not be  found to  bind  J1/tenascin-the 
mouse homolog of cytotactin (Grumet et al., 1985; Faissner 
et al.,  1988)-CTB proteoglycan appears to show different 
binding properties from astrochondrin (Hoffman  et al., 1988). 
The core proteins of CTB proteoglycan, astrochondrin and 
syneuran, however, share immunogenic determinants (Hoff- 
man, S., G. M.  Edelman, A.  Streit, A.  Faissner, and M. 
Schachner, unpublished observations). No immunochemical 
relationships between astrochondrin and the chondroitin sul- 
fate proteoglycans CAT 301 (Zaremba et al., 1989) and NG2 
(Stallcup and Beasley,  1987) were observed (Hockfield, S., 
W. B. Stallcup, A. Streit, and M. Schachner, unpublished 
observations). Furthermore, NG2 interacts specifically only 
with collagen type VI but not with other types of collagen 
(Stallcup et al., 1990),  whereas astrochondrin binds to dif- 
ferent collagen types but never to collagen type VI. 
Studies on the role of proteoglycans in the nervous system 
mainly focused on outgrowth and guidance of axons and pro- 
posed different  modes of  their action. However, less attention 
has been paid to their role in glial development. While as- 
trochondrin takes part in promoting process extension of as- 
trocytes, several other chondroitin and keratan sulfate pro- 
teoglycans have  been  shown  to  be  inhibitory  for  either 
neurite outgrowth (Verna  et al.,  1989;  Muir et al.,  1989; 
Snow et al.,  1990,  1991; Fichard et al.,  1991; Cole and 
McCabe, 1991; Oohira et al., 1991) or neuronal cell migra- 
tion (Tan et al.,  1987; Perris and Johansson,  1987, 1990; 
Perris and Bronner-Fraser, 1989).  Furthermore, also chon- 
droitin sulfate proteoglycans from non-neural tissue, e.g., 
decorin (Schmidt et al., 1987), appear to decrease cell adhe- 
sion  (Lark et al.,  1985, Culp  et al.,  1978),  and several 
models for the interaction between these various molecules, 
cell surface receptors, such as integrins, and the extracellu- 
lar matrix have been proposed (for review see Ruoslahti, 
1988, 1989). Additionally, these molecules modify cell mo- 
tility and invasive behaviour of metastatic cells (Schrappe et 
al., 1991; Faassen et al., 1992), processes which seem to be 
proportional to the expression of chondroitin sulfate pro- 
teoglycans (Iozzo,  1985).  On the other hand, chondroitin 
sulfate proteoglycans (Iijima et al., 1991) and different hepa- 
ran sulfate proteoglycans have been implicated in neurite 
outgrowth promotion (Lander et al., 1983; Dow et al., 1988; 
Riopelle and Dow,  1990).  Moreover, there is evidence that 
proteoglycans, such as syndecan as a cell surface receptor 
for extracellular matrix components (for review see Jalkanen 
et al., 1991), CD44 as a ligand for extracellular matrix and 
cell surface molecules (for review see Jalkanen et al., 1991) 
or heparan sulfate proteoglycans as components of adher- 
ons  (Schubert and LaCorbiere,  1985;  Cole et al.,  1985; 
Schubert et el., 1983), play a role in mediating cell adhesion 
(see  also Couchman and H66k,  1989;  Wight,  1989)  and 
some of them are probably also involved in signal transduc- 
tion (see Jalkanen et al., 1991). Recently, fibronectin type III 
and  EGF-like  repeats  or  immunoglobulin-like domains, 
known to be important in other groups of molecules involved 
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for several proteoglycans, e.g.,  syndecan (Saunders et al., 
1989),  the  large  fibroblast-derived  proteoglycan  versican 
(Zimmermann  and Ruoslahti,  1989), decorin (Krusius and 
Ruoslahti,  1986),  the  aggregating  cartilage  proteoglycan 
(Doege et al.,  1987), and the basement membrane heparan 
sulfate  proteoglycan  (Noonan  et  al.,  1988;  Kallunki  and 
Tryggvason,  1992).  It will be interesting  to elucidate  the 
contribution of these domains to the various functional prop- 
erties of proteoglycans. 
The biological significance of the functional properties of 
astrochondrin in vitro is underscored by its increased expres- 
sion in the developing cerebellar cortex during the first two 
postnatal  weeks.  In this period,  important  morphogenetic 
events,  such as cerebellar granule  cell migration  and out- 
growth of newly generated radial Bergmann glial processes, 
take place. Immunohistochemical data show that astrochon- 
drin is localized at the cell surface of endfeet of astrocytes 
and Bergmann glia in apposition to the basal lamina of blood 
vessels and meninges. This spatially and temporally specific 
expression of astrochondrin in close association with its cel- 
lular and acellular binding  partners  is likely the basis for 
these interactions.  Thus, astrochondrin  may be responsible 
for the successful interaction  of astroglia  with endothelial 
cells, thereby constituting a prerequisite for the induction of 
the  blood-brain  barrier  by  astrocytes  (Janzer  and  Raft, 
1987). Furthermore,  astrochondrin expressed by Bergmann 
glia is involved in granule cell migration, perhaps in combi- 
nation  with laminin,  which has been reported  to be tran- 
siently expressed by astrocytes and Bergmann glia in vitro 
and in vivo (Liesi et al.,  1983; Liesi 1985a, b; Selak et al., 
1985). It is not known how astrochondrin may mediate gran- 
ule cell migration, since it is not detectably involved in neu- 
rite  extension  or  dislocation  of  neuronal  cell  bodies  in 
microexplant cultures. Nevertheless, astrochondrin may be 
important for the extension of Bergmann glial processes to- 
wards the pial surface-a prerequisite for the migration of 
granule cells. The biological significance of the transient ex- 
pression of astrochondrin on the cell surface of parallel fibers 
during the period of active axon outgrowth is presently un- 
known, since astrochondrin  is not expressed by neurons in 
vitro (Streit et al., 1990). It is possible that neurons have lost 
the ability to synthesize astrochondrin  in vitro or that as- 
trochondrin is released by astroglia and absorbed to the ax- 
onal cell surface by its receptor(s) in vivo. It is noteworthy 
in this context that also the astrocyte-associated extraceUular 
matrix molecule J1/tenascin (Kruse et al.,  1985; Faissner et 
al.,  1988)  is detectable on axons  in the developing optic 
nerve and cerebellum (Bartsch et al.,  1992a, b). It is there- 
fore tempting to speculate that astrochondrin may subserve 
a functional role in the formation of axonal processes, which 
could, however, not be observed in the in vitro assay systems. 
Finally, our results suggest that not only astrochondrin, 
but the L5 carbohydrate epitope expressed by it, may medi- 
ate and/or stabilize process outgrowth by astrocytes. It is im- 
portant to mention that astrochondrin  is the only molecule 
on astrocytes and by far the predominant molecule in brain 
carrying the L5 epitope. Interestingly, another carbohydrate 
structure, the L2/HNK-1 epitope, which is also expressed by 
astrochondrin (Streit et al.,  1990) and several neural recog- 
nition molecules (Kruse et al., 1984, 1985; Schachner et al., 
1990) plays an important role as a ligand in astrocyte-lami- 
nin interactions (Kiinemund et al.,  1988). However, in con- 
trast to the L5 carbohydrate, the L2/HNK-1 carbohydrate ap- 
pears  to be directly  involved in  the  initial  attachment  of 
astrocytes to laminin  (Liu, L., H. Hall,  M.  Schachner,  B. 
Schmitz,  submitted  for  publication).  Thus,  carbohydrate 
structures  as  posttranslational  modifications  may  be  in- 
strumental in influencing and modifying cellular behaviour 
by their  specific temporal  expression patterns  possibly on 
even one and the same protein backbone (Schachner et al., 
1990).  Further  investigations  will elucidate the functional 
roles of carbohydrates in cell interactions and the structural 
basis underlying these interactions. 
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